GUIDELINE FOR THE USE OF RED BLOOD CELL PRODUCTS BASED ON SCIENTIFIC EVIDENCE (REVISION 2ND EDITION)-Reference-Cited by-同舟云学术

GUIDELINE FOR THE USE OF RED BLOOD CELL PRODUCTS BASED ON SCIENTIFIC EVIDENCE (REVISION 2ND EDITION)

Published:2018-12-25 Issue:6 Volume:64 Page:688-699
ISSN:1881-3011
Container-title:Japanese Journal of Transfusion and Cell Therapy
language:en
Short-container-title:JJTC

Author:

Yonemura Yuji¹²,Matsumoto Masanori³²,Inada Eiichi⁴²,Ueda Yasunori⁵²,Ohishi Kohshi⁶²,Kubo Takahiko⁷²,Kumakawa Midori⁸²,Sueoka Eizaburo⁹²,Sonoki Takashi¹⁰²,Nagai Kazuhiro¹¹²,Fujishima Naohito¹²²,Matsushita Tadashi¹³²

Affiliation:

1. Department of Transfusion Medicine and Cell Therapy, Kumamoto University Hospital

2. Guideline Committee of the Japan Society of Transfusion Medicine and Cell Therapy. Task Force Committee on the guideline for the use of red blood cell preparation

3. Department of Transfusion Medicine, Nara Medical University

4. Department of Anesthesiology and Pain Medicine, Juntendo University Faculty of Medicine

5. Department of Hematology/Oncology, Kurashiki Central Hospital

6. Transfusion Medicine and Cell Therapy, Mie University Hospital

7. Shirota Obsterical and Gynecological Hospital

8. Division of Transfusion Medicine, Fukuoka University Hospital

9. Clinical Laboratory, Saga Medical University

10. Department of Hematology/Oncology, Wakayama Medical University

11. Transfusion and Cell Therapy Unit, Nagasaki University Hospital

12. Division of Blood Transfusion, Akita University Hospital

13. Department of Transfusion Service, Nagoya University Hospital

Publisher

Japan Society of Transfusion Medicine and Cell Therapy

Subject

Computer Networks and Communications,Hardware and Architecture,Software

Link

https://www.jstage.jst.go.jp/article/jjtc/64/6/64_688/_pdf

Reference67 articles.

1. 1) 米村雄士, 松本雅則, 稲田英一, 他: 科学的根拠に基づいた赤血球製剤の使用ガイドライン. 日本輸血細胞治療学会誌, 62: 641-650, 2016.

2. 2) 福井次矢, 山口直人: 「Minds診療ガイドライン作成の手引き2014」. 医学書院, 2014.

3. 3) 「難治性貧血の診療ガイド」編集委員会: 難治性貧血の診療ガイド～特発性造血障害の病態・診断・治療の最新動向, 南江堂, 2011.

4. 4) Simon TL, Alverson DC, AuBuchon J, et al: Practice parameter for the use of red blood cell transfusions: Developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med, 122: 130-138, 1998.

5. 5) Murphy MF, Wallington TB, Kelsey P, et al: Guidelines for the clinical use of red cell transfusions. Brit J Haematol, 113: 24-31, 2001.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, Safety, and Quality of Life of Pegcetacoplan in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria Treated within the Phase 3 PEGASUS Trial;Acta Haematologica;2024-04-17

2. EFFORTS AT OUR HOSPITAL TO REDUCE THE DISPOSAL RATE OF RED BLOOD CELLS;Japanese Journal of Transfusion and Cell Therapy;2021-02-25